Zobrazeno 1 - 10
of 164
pro vyhledávání: '"Lazarou L"'
Publikováno v:
Research and Reports in Urology, Vol Volume 10, Pp 189-193 (2018)
Panagiotis Mourmouris, Marinos Berdempes, Titos Markopoulos, Lazaros Lazarou, Lazaros Tzelves, Andreas Skolarikos Second Department of Urology, Athens Medical School, National and Kapodistrian University of Athens, Sismanogleio General Hospital, Athe
Externí odkaz:
https://doaj.org/article/5482a6e43b164235ada5b70bae2e00db
Autor:
Tzelves, L., Glykas, I. *, Lazarou, L., Zabaftis, C., Fragkoulis, C., Leventi, A., Moulavasilis, N., Tzavellas, D., Tsirkas, K., Ntoumas, K., Mourmouris, P., Dellis, A., Varkarakis, I., Skolarikos, A., Liatsikos, E., Gkialas, I.
Publikováno v:
In Actas Urológicas Españolas (English Edition) October 2021 45(8):537-544
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Purpose: Artificial intelligence is part of our daily life and machine learning techniques offer possibilities unknown until now in medicine. This study aims to offer an evaluation of the performance of machine learning (ML) techniques, for predictin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::db4ce67340418f6394f0b32c394a614c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3220701
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3220701
Introduction: Currently, in prostate cancer, an increasing number of novel drugs are being used to delay its advancement to metastatic castration-resistant prostate cancer (mCRPC). Apalutamide, enzalutamide, and most recently, darolutamide (novel and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::0ca8e28b3b3e1033a48cc6897f7342c0
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020586
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020586
Introduction: The role of medical expulsive treatment (MET) is controversial. Fragility index is an additional metric to assess randomized controlled trials (RCTs) outcome validity and indicates how many patients would be required to convert a trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::c811fc892fa278bca501098e8e721e8f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119310
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119310
Renal cell carcinoma represents approximately 3% of all cancers, with the highest incidence occurring in the western world. Around 33% of the patients experience metastatic disease at diagnosis. Since the approval of the first targeted therapy, the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::297d1b9203fa1b4daf71da168212f4e2
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102571
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102571
Background and objectives: This is the first national survey assessing Greek Urology residency programs. The main objective of this study is to assess the level of confidence and perception of Greek Urology residents regarding their educational progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::47050695eb36d0e7065468655e2cd4ce
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3202182
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3202182
Autor:
Mitsogiannis, I.C. Kostakopoulos, N.A. Lazarou, L. Deliveliotis, K. Karagiotis, T. Deliveliotis, C.
Background: Renal hematomas, although relatively rare, are potentially life-threatening complications after ureterolithotripsy. Case Presentation: We present four cases of renal hematomas that occurred in our department during the past decade (2008-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::e88ff25f835dfa9a833284a64e7aafd8
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104685
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104685